PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Dasatinib 39.5mg tablets
0801050ANAAAIAI
Dasatinib Dasatinib Malignant Disease and Immunosuppression No data available
Dasatinib 50mg tablets
0801050ANAAABAB
Dasatinib Dasatinib Malignant Disease and Immunosuppression No data available
Dasatinib 63.2mg tablets
0801050ANAAAJAJ
Dasatinib Dasatinib Malignant Disease and Immunosuppression No data available
Dasatinib 70mg tablets
0801050ANAAACAC
Dasatinib Dasatinib Malignant Disease and Immunosuppression No data available
Dasatinib 79mg tablets
0801050ANAAAKAK
Dasatinib Dasatinib Malignant Disease and Immunosuppression No data available
Dasatinib 80mg tablets
0801050ANAAAFAF
Dasatinib Dasatinib Malignant Disease and Immunosuppression No data available
Daunorubicin (liposomal) 50mg/25ml inf vials
0801020J0AAAAAA
Daunorubicin Daunorubicin Malignant Disease and Immunosuppression No data available
Daunorubicin 20mg powder for solution for infusion vials
0801020J0AAABAB
Daunorubicin Daunorubicin Malignant Disease and Immunosuppression No data available
DaunoXome 50mg/25ml concentrate for inf vials
0801020J0BBAAAA
DaunoXome Daunorubicin Malignant Disease and Immunosuppression No data available
Decitabine 50mg powder for solution for infusion vials
0801030AEAAAAAA
Decitabine Decitabine Malignant Disease and Immunosuppression No data available
DepoCyte 50mg/5ml suspension for injection vials
0801030D0BEAAAN
Depocyte Cytarabine Malignant Disease and Immunosuppression No data available
Dexrazoxane 500mg powder for solution for infusion vials
0801000Y0AAAAAA
Dexrazoxane Dexrazoxane Malignant Disease and Immunosuppression No data available
Diethylstilbestrol 5mg tablets
0803010K0AAALAL
Diethylstilbestrol (Systemic) Diethylstilbestrol Malignant Disease and Immunosuppression No data available
Dimethyl fumarate 120mg gastro-resistant capsules
0802040AKAAAAAA
Dimethyl fumar Dimethyl fumar Malignant Disease and Immunosuppression No data available
Dimethyl fumarate 240mg gastro-resistant capsules
0802040AKAAABAB
Dimethyl fumar Dimethyl fumar Malignant Disease and Immunosuppression No data available
Disodium folinate 100mg/2ml solution for injection vials
0801000X0AAAAAA
Disodium folinate Disodium folinate Malignant Disease and Immunosuppression No data available
Disodium folinate 200mg/4ml solution for injection vials
0801000X0AAADAD
Disodium folinate Disodium folinate Malignant Disease and Immunosuppression No data available
Disodium folinate 400mg/8ml solution for injection vials
0801000X0AAABAB
Disodium folinate Disodium folinate Malignant Disease and Immunosuppression No data available
Disodium folinate 50mg/1ml solution for injection vials
0801000X0AAAEAE
Disodium folinate Disodium folinate Malignant Disease and Immunosuppression No data available
Disodium folinate 900mg/18ml solution for injection vials
0801000X0AAACAC
Disodium folinate Disodium folinate Malignant Disease and Immunosuppression No data available
Docetaxel 140mg/7ml solution for infusion vials
0801050D0AAAHAH
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 160mg/16ml solution for infusion vials
0801050D0AAAGAG
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 160mg/8ml solution for infusion vials
0801050D0AAAIAI
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 20mg/0.5ml solution for infusion vials and diluent
0801050D0AAAAAA
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available
Docetaxel 20mg/0.72ml inf vials and diluent
0801050D0AAALAL
Docetaxel Docetaxel Malignant Disease and Immunosuppression No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.